China Biologic Reports Financial Results for the First Quarter of 2018
–1Q18 Total Sales Up 13.7% YoY and Non-GAAP Adjusted Net Income Up 2.1% YoY in RMB terms, or Total Sales Up 23.0% YoY to $112.5 Million and Net Income Up…
10 Years of Digital Chest Drainage: Medela’s Milestones Show How State-Of-The-Art Technology Has Transformed Today’s Post-Operative Patient Care
BAAR, Switzerland , May 3, 2018 /PRNewswire/ — From Heber-principle to digital systems, thoracic surgery has significantly changed and improved over the course of time – so has chest drainage.…
AGC Biologics Enters into Commercial Manufacturing Agreement with Horizon Pharma plc
Manufacture of teprotumumab for treatment of thyroid eye disease COPENHAGEN, Denmark, May 3, 2018 /PRNewswire/ — AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced…
Beckman Coulter Achieves CE Mark for Its Early Sepsis Indicator*
First-of-its-kind hematology-based test intended to alert emergency department clinicians to the possibility of sepsis or risk of developing sepsis as part of a routine CBC with differential test BREA, California,…
World Smile Day: Smiling Shenyang Sets Its Sail Again to Create the Most Beautiful World Map
SHENYANG, China, May 3, 2018 /PRNewswire/ — On 8th May, 2018, the smile-drifting book Hello Smile 4.0 will start a new journey from Shenyang. As this year’s smile-bridge, Shenyang Broadcasting…
Sinovac Forced to Temporarily Suspend Flu Vaccine Production Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing
BEIJING, May 1, 2018 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac ” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it has been forced…
Beckman Coulter Launches the DxH 900 Hematology Analyzer
System helps laboratories deliver fast, accurate results through near native-state cellular characterization, precise flagging and a 93% first-pass throughput BREA, California, May 2, 2018 /PRNewswire/ — Beckman Coulter announced today…
Sinovac Forced to Plan to Destroy Bacterial Seeds intended for Pneumo Vaccine Production and Postpone Site Inspection
BEIJING, April 30, 2018 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it has been forced to…
Concord Medical Files 2017 Annual Report on Form 20-F
BEIJING, May 1, 2018 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solutions provider and operator of a network…
GC Pharma Reports Q1 2018 Results
-Efficiency improvement and pipeline progress remain top priorities YONGIN, South Korea, April 27, 2018 /PRNewswire/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical…
